Confidence interval for PK and PD analysis [General Sta­tis­tics]

posted by VijithRoy – India, 2021-03-04 11:03 (705 d 05:07 ago) – Posting: # 22241
Views: 1,271

❝ There are lots of 90% CI's used in PD, so in order to get towards an answer for your question can you please give a lot more context including: Where do you submit the dossier, what drug is it, what is your endpoint, did you get sc.advice or do a controlled correspondence with the authority etc?


Dear ElMaestro,

I was assuming that 95% CI uses for PD and 90% CI for PK analysis.
So setting up the CI depends upon our Statistical Modeling?


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5[Helmut]

With Best Regards,
Vroy.

Complete thread:

UA Flag
Activity
 Admin contact
22,485 posts in 4,710 threads, 1,603 registered users;
13 visitors (0 registered, 13 guests [including 4 identified bots]).
Forum time: 16:11 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5